Overall genotype frequencies of the GOLGB1 Y1212C mutation in all tested cohorts
| . | Frequency of the GOLGB1 Y1212C mutation in all cohorts . | ||
|---|---|---|---|
| Cohort . | YY (%) . | YC (%) . | CC (%) . |
| All SCA controls (n = 335) | 80.3 | 19.7 | 0.0 |
| Non-SCA controls (n = 91) | 83.5 | 15.4 | 1.1 |
| All stroke patients (n = 177) | 94.4 | 5.6 | 0.0 |
| Silent infarction cohort (n = 48) | 93.8 | 6.2 | 0.0 |
| Abnormal TCD cohort (n = 117) | 92.3 | 7.7 | 0.0 |
| . | Frequency of the GOLGB1 Y1212C mutation in all cohorts . | ||
|---|---|---|---|
| Cohort . | YY (%) . | YC (%) . | CC (%) . |
| All SCA controls (n = 335) | 80.3 | 19.7 | 0.0 |
| Non-SCA controls (n = 91) | 83.5 | 15.4 | 1.1 |
| All stroke patients (n = 177) | 94.4 | 5.6 | 0.0 |
| Silent infarction cohort (n = 48) | 93.8 | 6.2 | 0.0 |
| Abnormal TCD cohort (n = 117) | 92.3 | 7.7 | 0.0 |
The frequency of individuals' wild-type (YY), heterozygous (YC), and homozygous (CC) for the GOLGB1 Y1212C mutation are given for each cohort.